Old HIV drug shows promise against rare skin cancer
NCT ID NCT03077451
First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 15 times
Summary
This study tested the drug nelfinavir, originally used for HIV, in 36 adults with Kaposi sarcoma (a type of skin cancer). The goal was to see if it could shrink or eliminate skin lesions. Participants took standard or high doses, and researchers measured how many responded to treatment. The trial is complete, and results help guide future use of nelfinavir for this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN KAPOSI SARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
African Cancer Institute, Stellenbosch University
Cape Town, South Africa
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Benaroya Research Institute at Virginia Mason Medical Center
Seattle, Washington, 98101, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Emory University/Grady Hospital
Atlanta, Georgia, 30308, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Montefiore Medical Center
The Bronx, New York, 10461, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231-2410, United States
-
Uganda Cancer Institute
Kampala, Uganda
-
University of Miami
Miami, Florida, 33136, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.